March 5, 2018
The Ministry of Health, Labor and Welfare (MHLW) announced new NHI reimbursement drug prices effective April 1 in the official gazette on March 5, revealing that Opdivo (nivolumab) was the only drug subject to a new post-launch downward adjustment based...read more